$东阳光药(0688_老虎社区_美港股上老虎

$东阳光药(06887)$ LT3抑制剂克立福替尼是国内首个进入III期临床的国产同类药物，全球销售峰值潜力10亿美元，已与三生制药达成商业化合作，6000万首付款落袋为安。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":489080369385848,"tweetId":"489080369385848","gmtCreate":1760431321001,"gmtModify":1760431323067,"author":{"id":4121743414308690,"idStr":"4121743414308690","authorId":4121743414308690,"authorIdStr":"4121743414308690","name":"节操掉了下来","avatar":"https://static.tigerbbs.com/b93ec685b5570c07511976a6e20cf908","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":0,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/06887\">$东阳光药(06887)$</a> &nbsp;LT3抑制剂克立福替尼是国内首个进入III期临床的国产同类药物，全球销售峰值潜力10亿美元，已与三生制药达成商业化合作，6000万首付款落袋为安。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/06887\">$东阳光药(06887)$</a> &nbsp;LT3抑制剂克立福替尼是国内首个进入III期临床的国产同类药物，全球销售峰值潜力10亿美元，已与三生制药达成商业化合作，6000万首付款落袋为安。</p></body></html>","text":"$东阳光药(06887)$ LT3抑制剂克立福替尼是国内首个进入III期临床的国产同类药物，全球销售峰值潜力10亿美元，已与三生制药达成商业化合作，6000万首付款落袋为安。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/489080369385848","repostId":0,"isVote":1,"tweetType":1,"viewCount":359,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["06887"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":147,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}